Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses —197.52 K— — Research & development ——— — Operating income —-197.52 K— — Non-Operating Income, Total —1.27 M— — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses —1.27 M— — Unusual income/expense ——— — Pretax income —1.07 M— — Equity in earnings ——— — Taxes —0— — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations —1.07 M— — Discontinued operations ——— — Net income —1.07 M— — Dilution adjustment —29.25 M— — Preferred dividends —29.29 M— — Diluted net income available to common stockholders —1.03 M— — Basic earnings per share (Basic EPS) —0.12— — Diluted earnings per share (Diluted EPS) —0.12— — Average basic shares outstanding 7.5 M17.7 M28.84 M — Diluted shares outstanding 7.5 M18.49 M29.19 M — EBITDA ——— — EBIT ——— — Cost of revenue ——— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) ——— —